ROMA-PRE LIS Code: ROMA-PRE
Assess ovarian cancer risk in premenopausal women with the ROMA test. Accurate private testing with fast results.
Test Categories
About this test
Overview of the ROMA™ Test
The Risk of Ovarian Malignancy Algorithm (ROMA™) test is designed to evaluate the likelihood of ovarian cancer in women presenting with a pelvic mass.
Key Factors Assessed
The test combines measurements of HE4 and CA125 biomarkers along with the patient’s menopausal status.
Purpose and Clinical Use
ROMA™ helps healthcare providers assess the risk of ovarian malignancy to support timely and accurate clinical decision-making.